Skip to main content

Market Overview

20 Stocks Moving In Thursday's Pre-Market Session

Share:

Gainers

  • Zynerba Pharmaceuticals Inc (NASDAQ: ZYNE) gained 88.2 percent to $11.65 after the company reported top line results in ZYN002 open label Phase 2 FAB-C study in children with Fragile X syndrome. The study successfully met the primary endpoint.
  • Exa Corp (NASDAQ: EXA) rose 42.4 percent to $24.15 in pre-market trading. Dassault Systèmes announced plans to acquire Exa for $24.25 per share in cash.
  • Sky Solar Holdings Ltd (ADR) (NASDAQ: SKYS) shares rose 38 percent to $2.25 in the pre-market trading session. Sky Solar posted net income of $5.2 million in the first half of 2017, versus a net loss of $2.2 million in the year-ago period.
  • Aqua Metals Inc (NASDAQ: AQMS) rose 32.2 percent to $8.00 in pre-market trading after gaining 3.95 percent on Wednesday.
  • Chiasma Inc (NASDAQ: CHMA) shares rose 10.2 percent to $2.70 in pre-market trading. Chiasma reported that initial patient is randomized in Phase 3 CHIASMA OPTIMAL clinical trial.
  • Izea Inc (NASDAQ: IZEA) rose 8.3 percent to $6.40 in pre-market trading after falling 10.73 percent on Wednesday.
  • BlackBerry Ltd (NASDAQ: BBRY) shares rose 7.3 percent to $9.90 in pre-market trading after the company reported stronger-than-expected earnings for its second quarter and reported signing of first BlackBerry secure licensing deal.
  • Editas Medicine Inc (NASDAQ: EDIT) rose 5.7 percent to $21.06 in pre-market trading after declining 1.82 percent on Wednesday.
  • RedHill Biopharma Ltd - ADR (NASDAQ: RDHL) rose 5.1 percent to $9.55 in pre-market trading after dropping 3.91 percent on Wednesday.
  • Dr.Reddy's Laboratories Ltd (ADR) (NYSE: RDY) rose 4.5 percent to $36.06 in pre-market trading after dropping 3.31 percent on Wednesday.
  • Abbott Laboratories (NYSE: ABT) rose 4.2 percent to $54.30 in pre-market trading after the company disclosed that the FDA has approved Abbott Freestyle Libre Flash Glucose Monitoring System.
  • Rex Energy Corporation (NASDAQ: REXX) rose 3.6 percent to $2.85 in pre-market trading after surging 17.02 percent on Wednesday.

Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

Losers

  • DexCom, Inc. (NASDAQ: DXCM) fell 26.6 percent to $49.55 in pre-market trading following the FDA approval of Abbott's Blood Glucose Monitoring Device and analyst downgrades.
  • Pier 1 Imports Inc (NYSE: PIR) shares fell 9.6 percent to $4.06 in pre-market trading. Pier 1 Imports posted a narrower-than-expected loss for its second quarter. The company’s comparable sales rose 1.8 percent during the quarter.
  • ITUS Corp (NASDAQ: ITUS) shares fell 6.7 percent to $4.06 in pre-market trading after dropping 12.83 percent on Wednesday.
  • Veritone Inc (NASDAQ: VERI) shares fell 6.4 percent to $43.00 after dipping 30.28 percent on Wednesday.
  • Helios and Matheson Analytics Inc (NASDAQ: HMNY) fell 6.1 percent to $8.20 in pre-market trading after declining 5.25 percent on Wednesday.
  • Meritor Inc (NYSE: MTOR) fell 5.7 percent to $25.10 in pre-market trading after rising 1.03 percent on Wednesday.
  • 22nd Century Group Inc (NYSE: XXII) shares fell 4.1 percent to $2.60 in pre-market trading after slipping 1.09 percent on Wednesday.
  • Rite Aid Corporation (NYSE: RAD) fell 3.1 percent to $2.21 in pre-market trading after the company posted downbeat quarterly sales and named Kermit Crawford as President and COO.
 

Related Articles (ABT + AQMS)

View Comments and Join the Discussion!

Posted-In: #PreMarket Gainers LosersNews Movers & Shakers Pre-Market Outlook Markets Movers

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com